Anne Moreau

Author PubWeight™ 62.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica 2007 3.23
2 Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci U S A 2007 2.27
3 Kidney and recipient weight incompatibility reduces long-term graft survival. J Am Soc Nephrol 2010 2.08
4 Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. Blood 2005 1.99
5 A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Blood 2005 1.86
6 Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 2006 1.75
7 Variation in numbers of CD4+CD25highFOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome. Transpl Int 2007 1.65
8 Absence of Nodal signaling promotes precocious neural differentiation in the mouse embryo. Dev Biol 2006 1.61
9 Temporal arteritis associated with systemic necrotizing vasculitis. J Rheumatol 2003 1.57
10 Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. Am J Pathol 2003 1.38
11 Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol 2005 1.36
12 Initiation of gastrulation in the mouse embryo is preceded by an apparent shift in the orientation of the anterior-posterior axis. Curr Biol 2004 1.35
13 Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood 2007 1.20
14 Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells. J Immunol 2006 1.20
15 Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis. J Pathol 2010 1.11
16 Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol 2009 1.09
17 Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation? Eur J Nucl Med Mol Imaging 2009 1.07
18 Regulatory, effector, and cytotoxic T cell profiles in long-term kidney transplant patients. J Am Soc Nephrol 2009 1.05
19 Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients. Transplantation 2008 1.04
20 Immunosuppressive drug-free operational immune tolerance in human kidney transplant recipients: Part I. Blood gene expression statistical analysis. J Cell Biochem 2008 1.03
21 Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma. J Clin Oncol 2012 1.02
22 Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group. Eur J Nucl Med Mol Imaging 2010 0.99
23 ABT-737 induces apoptosis in mantle cell lymphoma cells with a Bcl-2high/Mcl-1low profile and synergizes with other antineoplastic agents. Clin Cancer Res 2011 0.96
24 Clonal and molecular analysis of the prospective anterior neural boundary in the mouse embryo. Development 2012 0.92
25 Systemic vasculitis with lymphocytic temporal arteritis and Toxocara canis infection. Arch Intern Med 2002 0.92
26 Nodal cis-regulatory elements reveal epiblast and primitive endoderm heterogeneity in the peri-implantation mouse embryo. Dev Biol 2010 0.90
27 Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis. Drug Des Devel Ther 2013 0.88
28 Identification of pyruvate kinase in methicillin-resistant Staphylococcus aureus as a novel antimicrobial drug target. Antimicrob Agents Chemother 2011 0.88
29 A non-randomised dose-escalating phase II study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes: the Thal-SMD-2000 trial of the Groupe Français des Myélodysplasies. Br J Haematol 2005 0.85
30 Immunoproteasome beta subunit 10 is increased in chronic antibody-mediated rejection. Kidney Int 2010 0.85
31 Is ASCT with TBI superior to ASCT without TBI in mantle cell lymphoma patients? Transplantation 2012 0.84
32 Reduced-intensity conditioning allogeneic stem cell transplant for relapsed or transformed aggressive B-cell non-Hodgkin lymphoma. Leuk Lymphoma 2010 0.83
33 Implication of matrix metalloproteinase 7 and the noncanonical wingless-type signaling pathway in a model of kidney allograft tolerance induced by the administration of anti-donor class II antibodies. J Immunol 2008 0.83
34 Photo quiz. Generalized pain in a 20-year-old man with chronic granulomatous disease. Clin Infect Dis 2013 0.82
35 Comparative toxicity and efficacy of combined radioimmunotherapy and antiangiogenic therapy in carcinoembryonic antigen-expressing medullary thyroid cancer xenograft. J Nucl Med 2010 0.82
36 Anti-topoisomerase I antibodies in systemic lupus erythematosus as a marker of severe nephritis. Clin Rheumatol 2006 0.81
37 The spectrum of renal involvement in patients with inflammatory myopathies. Medicine (Baltimore) 2014 0.81
38 Exceptional osseous and meningeal spinal localization of ANCA-associated granulomatous vasculitis with hypertrophic spinal pachymeningitis. J Neurol 2011 0.80
39 Optimization and structure-activity relationships of a series of potent inhibitors of methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase as novel antimicrobial agents. Bioorg Med Chem 2012 0.80
40 Dominant tolerance to kidney allografts induced by anti-donor MHC class II antibodies: cooperation between T and non-T CD103+ cells. J Immunol 2006 0.79
41 Increased soluble Flt-1 correlates with delayed graft function and early loss of peritubular capillaries in the kidney graft. Transplantation 2013 0.79
42 18-F FDG-PET in the staging of lymphocyte-predominant Hodgkin's disease. Haematologica 2008 0.79
43 Damage in agitated vessels of large visco-elastic particles dispersed in a highly viscous fluid. J Food Sci 2011 0.79
44 hCTLA4-Ig transgene expression in keratocytes modulates rejection of corneal xenografts in a pig to non-human primate anterior lamellar keratoplasty model. Xenotransplantation 2014 0.78
45 Renal phenotypic variability in HDR syndrome: glomerular nephropathy as a novel finding. Eur J Pediatr 2012 0.78
46 Sarcoidosis diagnosed in elderly subjects: retrospective study of 30 cases. Chest 2004 0.78
47 Design and synthesis of novel bone-targeting dual-action pro-drugs for the treatment and reversal of osteoporosis. Bioorg Med Chem 2012 0.78
48 T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy? Hum Pathol 2007 0.77
49 Cheminformatics-driven discovery of selective, nanomolar inhibitors for staphylococcal pyruvate kinase. ACS Chem Biol 2011 0.77
50 Tolerance induction in rats, using a combination of anti-CD154 and donor splenocytes, given once on the day of transplantation. Transplantation 2003 0.77
51 [Primary adrenal angiosarcoma]. Ann Pathol 2004 0.77
52 Association of rapamycin and co-stimulation blockade using anti-B7 antibodies in renal allotransplantation in baboons. Nephrol Dial Transplant 2004 0.77
53 Cellular participation in delayed xenograft rejection of hCD55 transgenic pig hearts by baboons. Xenotransplantation 2003 0.76
54 Injectable calcium phosphate scaffold and bone marrow graft for bone reconstruction in irradiated areas: an experimental study in rats. Biomaterials 2006 0.76
55 Long-term follow-up of tandem high-dose therapy with autologous stem cell support for adults with high-risk age-adjusted international prognostic index aggressive non-Hodgkin Lymphomas: a GOELAMS pilot study. Biol Blood Marrow Transplant 2010 0.76
56 T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study. Clin Immunol 2006 0.76
57 The effect of immunoglobulin immunadsorptions on delayed xenograft rejection of human CD55 transgenic pig kidneys in baboons. Xenotransplantation 2003 0.76
58 Homozygous PTEN deletion in neuroblastoma arising in a child with Cowden syndrome. Am J Med Genet A 2011 0.76
59 Is continuous subglottic suctioning cost-effective for the prevention of ventilator-associated pneumonia? Infect Control Hosp Epidemiol 2011 0.76
60 CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality. Transpl Int 2014 0.75
61 [Definition and classification of infiltrating tumors of the bladder]. Prog Urol 2002 0.75
62 [Crescentic glomerulonephritis]. Nephrol Ther 2006 0.75
63 Quiz page February 2012: acute kidney injury in an adolescent with a family history of autoimmune disorders. Am J Kidney Dis 2012 0.75
64 [Management of a cystectomy specimen: total cysto-prostatectomy or anterior pelvic surgery]. Prog Urol 2002 0.75
65 Early protocol biopsies in pediatric renal transplantation: interest for the adaptation of immunosuppression. Pediatr Transplant 2013 0.75
66 [Histologic prognosis of infiltrating urothelial tumors]. Prog Urol 2002 0.75
67 [A rare subcutaneous tumor]. Ann Pathol 2012 0.75
68 Exhaustive depletion of graft resident dendritic cells: marginally delayed rejection but strong alteration of graft infiltration. Transplantation 2005 0.75
69 [Pathologic anatomy of infiltrating non-epithelial tumors of the bladder]. Prog Urol 2002 0.75
70 Autoimmune responses against renal tissue proteins in long-term surviving allograft recipients. Transpl Int 2009 0.75
71 [Pathologic anatomy of infiltrating epithelial tumors of the bladder]. Prog Urol 2002 0.75
72 [Kikuchi-Fujimoto disease: two cases]. Ann Med Interne (Paris) 2003 0.75